Pharmadrug Pink Sheet Forecast - Triple Exponential Smoothing

Pharmadrug Additional Predictive Modules

Most predictive techniques to examine Pharmadrug price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharmadrug using various technical indicators. When you analyze Pharmadrug charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. Triple exponential smoothing for Pharmadrug - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Pharmadrug prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Pharmadrug price movement. However, neither of these exponential smoothing models address any seasonality of Pharmadrug.

Pharmadrug Triple Exponential Smoothing Price Forecast For the 28th of January

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Pharmadrug on the next trading day is expected to be 0.01 with a mean absolute deviation of 0, mean absolute percentage error of 0.00000418, and the sum of the absolute errors of 0.09.

Pharmadrug Pink Sheet Forecast Pattern

Backtest Pharmadrug

Pharmadrug Price Prediction

Buy or Sell Advice

Pharmadrug Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Pharmadrug pink sheet data series using in forecasting. Note that when a statistical model is used to represent Pharmadrug pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. As with simple exponential smoothing, in triple exponential smoothing models past Pharmadrug observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Pharmadrug observations.

Predictive Modules for Pharmadrug

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmadrug. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.01 17.54 Details

Intrinsic Valuation Low Real High 0.00 0.01 17.54 Details

Bollinger Band Projection (param) Low Middle High 0.01 0.01 0.02 Details

Pharmadrug After-Hype Price Density Analysis

Pharmadrug Estimiated After-Hype Price Volatility

Pharmadrug Pink Sheet Price Outlook Analysis

Notes

Pharmadrug Hype Timeline

Pharmadrug is now traded for 0.01. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. Pharmadrug is expected to decline in value after the next headline, with the price expected to drop to 0.01. The average volatility of media hype impact on the company price is over 100%. The price reduction on the next news is expected to be -12.28%, whereas the daily expected return is now at 1.9%. The volatility of related hype on Pharmadrug is about 2014942.53%, with the expected price after the next announcement by competition of 0.01. The company has price-to-book ratio of 0.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharmadrug recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of August 2016. Assuming the 90 days horizon the next expected press release will be in a few days. Check out Historical Fundamental Analysis of Pharmadrug to cross-verify your projections.

Pharmadrug Related Hype Analysis

Other Forecasting Options for Pharmadrug

For every potential investor in Pharmadrug, whether a beginner or expert, Pharmadrug's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pharmadrug Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pharmadrug. Basic forecasting techniques help filter out the noise by identifying Pharmadrug's price trends.

Pharmadrug Related Equities

Risk & Return

Correlation

Pharmadrug Market Strength Events

Pharmadrug Risk Indicators

Story Coverage note for Pharmadrug

Other Macroaxis Stories

Other Information on Investing in Pharmadrug Pink Sheet